Nitrazepam is indicated for:
the short-term treatment of insomnia when it is severe, disabling or subjecting the individual to unacceptable distress, where daytime sedation is acceptable.
An underlying cause for insomnia should be sought before deciding upon the use of benzodiazepines for symptomatic relief.
Benzodiazepines are not recommended for the primary treatment of psychotic illness.
Summary of Product Characteristics
Read this summary of product characteristics for further information about Nitrazepam Mixture Oral Suspension BP. Click below to navigate to the EMC.
Patient Information Leaflet
Read this patient information leaflet about Nitrazepam Mixture Oral Suspension BP, what it’s used for and possible side effects. Click below to navigate to the EMC.
Nitrazepam Mixture Oral Suspension BP
|Click here for Audio Version
|Store in a refrigerator (2°C - 8°C). Protect from light. Do not freeze.
|Shelf Life (Closed Bottle)
For further product information and pricing please use the form below and a member of the team will be in touch
Stay updated via our App
A new Rosemont Pharmaceuticals App for Healthcare Professionals is launching soon.